NFGH
BCYC

Nan Fung Group Holdings’s Bicycle Therapeutics BCYC Stock Holding History

Nan Fung Group Holdings’s Portfolio BCYC Stock Details BCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-68,943
Closed -$488K – 25
2025
Q4 		$488K Hold
68,943
– – 0.44% 24
2025
Q3 		$534K Hold
68,943
– – 0.9% 19
2025
Q2 		$479K Hold
68,943
– – 0.76% 16
2025
Q1 		$585K Hold
68,943
– – 0.48% 28
2024
Q4 		$965K Buy
68,943
+37,358
+118% +$801K 0.83% 25
2024
Q3 		$715K Buy
31,585
+14,285
+83% +$330K 0.62% 28
2024
Q2 		$350K Buy
+17,300
New +$391K 0.37% 29

Other funds holding BCYC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
GP
GSK plc London $599M AUM
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Nan Fung Group Holdings's BCYC Position: Q1 2026 in Review

Nan Fung Group Holdings sold out of Bicycle Therapeutics (BCYC) in Q1 2026, closing a stake of 68,943 shares — an estimated $488K sold.

Nan Fung Group Holdings first reported a position in BCYC in Q2 2024 and held it in 7 quarters. The position peaked at $965K in Q4 2024. 98 funds tracked by Wall St. Rank hold BCYC as of Q1 2026.

  • Nan Fung Group Holdings reported no remaining Bicycle Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Nan Fung Group Holdings sold 68,943 Bicycle Therapeutics shares in Q1 2026, an estimated $488K.
  • Nan Fung Group Holdings first reported a position in Bicycle Therapeutics in Q2 2024 and held it in 7 quarters.
  • Nan Fung Group Holdings's Bicycle Therapeutics position peaked at $965K in Q4 2024.
  • 98 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q1 2026.

Based on Nan Fung Group Holdings's 13F filing for Q1 2026, filed 14 May 2026.